Nephros
Nephros, Inc. is a commercial-stage company based in South Orange, New Jersey, dedicated to developing and selling high-performance water purification products for both medical and commercial markets. It operates through two segments: Water Filtration and Renal Products. In the medical sector, Nephros provides ultrafilters used in hospitals and dialysis centers to eliminate biological contaminants from water and bicarbonate concentrate, thereby enhancing infection control and patient safety. Additionally, the company offers hemodiafiltration systems that support nephrologists in treating patients with end-stage renal disease. In the commercial arena, Nephros manufactures water filters designed to improve water quality by reducing biofilm, bacteria, and scale buildup, serving markets such as food service and hospitality. Founded in 1997, Nephros continues to innovate in water purification technologies to improve healthcare outcomes and enhance operational efficiency across various applications.
GenArraytion Inc. is a veteran-owned small business offering products and services for medical diagnostics, including tick- and mosquito-borne disease and surveillance, epidemiology and source tracking, food and water testing, biodefense and environmental monitoring. Our MultiFLEX Bioassays and Sniper Sequencing genotyping services provide rapid, specific infectious disease assays that can improve infection disease response and treatment. GenArraytion has developed real-time multiplexed real-time PCR assays, multiplexed bead-based assays and custom microarrays for simultaneous detection of multiple pathogens and antimicrobial characterization of clinically relevant pathogens. GenArraytion is actively registered in the CCR database and is ORCA certified.
Biocon Biologics Limited, based in Bengaluru, India, is a subsidiary of Biocon Limited that specializes in the development and commercialization of biopharmaceutical solutions. Founded in 2016, the company focuses on producing high-quality, affordable biosimilars, novel biologics, and complex small molecule active pharmaceutical ingredients (APIs). Biocon Biologics operates with a commitment to enhancing patient access to advanced therapies, leveraging its robust capabilities in drug development and manufacturing. The company also engages in the production of generic formulations for markets in the U.S. and Europe, highlighting its global reach and dedication to making essential medications available to those in need.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.